期刊文献+

miR-134通过下调叉头盒蛋白M1抑制肝细胞癌细胞增殖

miR-134 suppresses proliferation in hepatocellular carcinoma cells by downregulating FOXM1
下载PDF
导出
摘要 目的探讨miR-134下调叉头盒蛋白M1(forkhead box M1,FOXM1)的机制及其影响肝细胞癌(hepatocellular carcinoma,HCC)细胞增殖的作用。方法应用CCK-8法检测miR-134对HCC细胞增殖的作用;经Western blot和Real-time PCR检测人正常肝细胞L02和5种HCC细胞系中FOXM1和miR-134的表达;用miR-134模拟物(miR-134 mimic)或miR-134抑制剂(miR-134 inhibitor)转染HCC细胞后,经Western blot和Real-time PCR检测FOXM1及其下游靶基因Cyclin D1的表达;应用生物信息学分析miR-134在人FOXM1 3'-UTR的可能结合位点,通过报告基因检测实验分析miR-134与FOXM1的3'-UTR的特异性结合;将miR-134 mimic和FOXM1表达质粒(无3'-UTR)共转染于HCC细胞后,经CCK-8法检测细胞的增殖情况。结果 miR-134可显著抑制HCC细胞增殖(P<0.05);与人正常肝细胞L02相比,miR-134在HCC细胞中的表达明显降低(P<0.05),而FOXM1蛋白表达明显增强,二者存在负相关(R2=0.705,P<0.05);miR-134可显著下调FOXM1蛋白及其下游靶基因Cyclin D1的表达(P<0.05);报告基因检测实验证实miR-134可特异性结合于FOXM1 mRNA的3'-UTR(P<0.01);细胞增殖实验检测结果显示,过表达缺失3'-UTR的FOXM1可显著减弱miR-134对HCC细胞增殖的抑制效应(P<0.05)。结论 miR-134通过靶向结合于FOXM1的3'-UTR而下调FOXM1蛋白的表达,从而抑制HCC细胞的增殖。 Objective To investigate the mechanism by which miR-134 regulates the expression of forkhead box M1 (FOXM1) and determine the effect of miR-134 on the proliferation of hepatocellular carcinoma cells (HCC). Methods The proliferation of HCC cells was analyzed by CCK=8 assay. The levels of FOXM1 and miR-134 were separately examined by Western blotting and real-time PCR in human normal hepatic cell line L02 and 5 kinds of HCC cell lines. After transfection with miR-134 mimic or inhibitor, the expression of FOXM1 and its target gene CyclinD1 in HCC cells were measured by Western blotting and real-time PCR. The potential binding site of miR-134 on the 3′ UTR of human FOXM1 mRNA was predicted by using online bioinformative databases. Then the luciferase reporter assays were performed to identify the specific binding of miR-134 with 3′ UTR of FOXM1 mRNA. After cotransfected with miR-134 mimic or FOXM1-expressing plasmids (without 3′ UTR), the HCC cell proliferation was detected by CCK-8 assay. Results miR-134 dramatically suppressed the proliferation of HCC cells (P〈0.05). Compared to normal liver cell line, L02 cells, miR-134 was lowly expressed while the FOXM1 protein was highly expressed in the HCC cells(P〈0.05), and a negative correlation was found between miR-134 level and FOXM1 protein level (R^2=0.705, P〈0.05). miR-134 significantly downregulated FOXM1 protein, and its downstream target gene, CyclinD1, in HCC cells (P〈0.05). The luciferase reporter assay showed that miR-134 specifically bound to the 3′UTR of FOXM1 mRNA (P〈0.01). The cell proliferation assay revealed that the ectopic expression of FOXM1 without 3′UTR in HCC cells significantly attenuated the miR-134-mediated growth inhibition of HCC cells (P〈0.05). Conclusion miR134 down-regulates FOXM1 protein by directly targeting the 3′ UTR of FOXM1 mRNA, and subsequently suppresses the proliferation of HCC cells.
作者 姜珊 熊浩君 何家琳 李波 杨帆 杨腾 张艳 何凤田 Jiang Shan Xiong Haojun He Jialin Li Bo Yang Fan Yang Teng Zhang Yan He Fengtian(Department of Biochemistry and Molecular Biology, College of Basic Medical Sciences, Third Military Medical University, Chongqing, 400038, Chin)
出处 《第三军医大学学报》 CAS CSCD 北大核心 2017年第1期1-8,共8页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(81672377 31470066)~~
关键词 癌细胞增殖 蛋白表达 肝细胞癌 CYCLIND1 HCC细胞 CARCINOMA CCK-8法 人正常肝细胞 miR-134 forkhead box M1 hepatocellular carcinoma cell proliferation
  • 相关文献

参考文献4

二级参考文献45

  • 1Xiao-Rong Wu,Yong-Hui Chen,Dong-Ming Liu,Jian-Jun Sha,Han-Qing Xuan,Juan-Jie Bo,Yi-Ran Huang.Increased expression of forkhead box M1 protein is associated with poor prognosis in clear cell renal cell carcinoma[J].Medical Oncology.2013(1)
  • 2Shan-yang He,Hong-wei Shen,Lin Xu,Xiao-hui Zhao,Li Yuan,Gang Niu,Ze-Shan You,Shu-zhong Yao.FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer[J].Gynecologic Oncology.2012(3)
  • 3Hong-Cheng Sun,Min Li,Ji-Lin Lu,Dong-Wang Yan,Chong-Zhi Zhou,Jun-Wei Fan,Xue-Bin Qin,Hua-Mei Tang,Zhi-Hai Peng.Overexpression of Forkhead box M1 protein associates with aggressivetumor features and poor prognosis of hepatocellular carcinoma[J].Oncology Reports.2011(6)
  • 4Inken Wierstra,Jürgen Alves.FOXM1, a typical proliferation-associated transcription factor[J].Biological Chemistry.2007(12)
  • 5Zhong Dong,R. Daniel Bonfil,Sreenivasa Chinni,Xiyun Deng,J. Carlos Trindade Filho,Margarida Bernardo,Ulka Vaishampayan,Mingxin Che,Bonnie F. Sloane,Shijie Sheng,Rafael Fridman,Michael L. Cher.Matrix Metalloproteinase Activity and Osteoclasts in Experimental Prostate Cancer Bone Metastasis Tissue[J].The American Journal of Pathology.2005(4)
  • 6Peng ZW,Chen MS,Liang HH,et al.A case-control study comparing percutaneous radiofrequency ablation alone or combined with transcatheter arterial chemoembolization for hepatocellular carcinoma[J].Eur Surg Oncol,2010,36(3):257-263.
  • 7Machi J,Bueno RS,Wong LL.Long-term follow-up outcome of patients undergoing radiofrequency ablation for unresectable hepatocellular carcinoma[J].World Surg,2012,29(11):1364-1373.
  • 8Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65:87-108 [PMID: 25651787 DOI: 10.3322/ caac.21262].
  • 9Langenfeld EM, Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2004; 2:141-149 [PMID: 15037653].
  • 10Alarmo EL, Rauta J, Kauraniemi P, Karhu R, Kuukasj:rvi T, Kallioniemi A. Bone morphogenetic protein 7 is widely overexpressed in primary breast cancer. Genes Chromosomes Cancer 2006; 45:411-419 [PMID: 16419056 DOI: 10.1002/gcc.20307].

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部